{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:16:51Z","timestamp":1762521411346},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Health"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.inhe.2010.12.001","type":"journal-article","created":{"date-parts":[[2011,1,24]],"date-time":"2011-01-24T06:30:56Z","timestamp":1295850656000},"page":"22-26","source":"Crossref","is-referenced-by-count":17,"title":["Coverage and compliance to mass drug administration for lymphatic filariasis elimination in a district of Kerala, India"],"prefix":"10.1093","volume":"3","author":[{"given":"Zinia T.","family":"Nujum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1016\/j.inhe.2010.12.001_bib0005","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1017\/S0031182000066646","article-title":"Reassessing the global prevalence and distribution of Lymphatic filariasis","volume":"112","author":"Michael","year":"1996","journal-title":"Parasitology"},{"key":"10.1016\/j.inhe.2010.12.001_bib0010","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/00034983.2000.11813582","article-title":"Mapping of L.F in India","volume":"95","author":"Sabesan","year":"2000","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.inhe.2010.12.001_bib0015","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0169-4758(00)01643-4","article-title":"The economic burden of LF in India","volume":"16","author":"Ramaiah","year":"2000","journal-title":"Parasitol Today"},{"key":"10.1016\/j.inhe.2010.12.001_bib0020","unstructured":"WHO. Lymphatic filariasis: the disease and its control. Fifth report of the WHO Expert Committee on Filariasis. Geneva: World Health Organization. Technical Report Series 821; 1992."},{"key":"10.1016\/j.inhe.2010.12.001_bib0025","unstructured":"Directorate NMEP. NFCP Operational manual. Delhi: NICD;1995."},{"key":"10.1016\/j.inhe.2010.12.001_bib0030","series-title":"Manual of entomological surveillance of vector borne diseases","author":"Rahman","year":"1989"},{"key":"10.1016\/j.inhe.2010.12.001_bib0035","first-page":"1","article-title":"Recommendations of the international task force for disease eradication","volume":"42","author":"Centers for Disease Control and Prevention","year":"1993","journal-title":"MMWR"},{"key":"10.1016\/j.inhe.2010.12.001_bib0040","unstructured":"Fiftieth World Health Assembly. Elimination of lymphatic filariasis as a public health problem. Resolution of the Excecutive Board of the WHO. 13 May 1997. Geneva: World Health Organization; 1997. WHA50.29;"},{"key":"10.1016\/j.inhe.2010.12.001_bib0045","first-page":"491","article-title":"Strategies and tools for the control elimination of Lymphatic filariasis","volume":"75","author":"Otteson","year":"1997","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.inhe.2010.12.001_bib0050","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-3156.1997.tb00157.x","article-title":"Ivermectin for the chemotherapy of bancroftian filariasis: a metaanalysis of the effect of single treatment","volume":"2","author":"Cao","year":"1997","journal-title":"Trop Med Int Heath"},{"key":"10.1016\/j.inhe.2010.12.001_bib0055","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0035-9203(98)90972-5","article-title":"Efficacy of single dose combinations of Ivermectin, Albendazole and DEC for the treatment of Bancroftian Filariasis","volume":"92","author":"Ismail","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.inhe.2010.12.001_bib0060","series-title":"Lymphatic filariasis, tropical medicine science and practice","author":"Thomas","year":"2000"},{"key":"10.1016\/j.inhe.2010.12.001_bib0065","unstructured":"WHO. Preparing and implementing a national plan to eliminate lymphatic filariasis. Geneva: World Health Organization; 2002. WHO\/CDS\/CPE\/CEE\/2000.15."},{"key":"10.1016\/j.inhe.2010.12.001_bib0070","first-page":"333","article-title":"Mass drug administration against lymphatic filariasis: experiences from Kozhikode district of Kerala state","volume":"38","author":"Regu","year":"2006","journal-title":"J Commun Dis"},{"key":"10.1016\/j.inhe.2010.12.001_bib0075","first-page":"93","article-title":"Observations on the application of EPI cluster survey methods for estimating disease incidence","volume":"63","author":"Rothenberg","year":"1985","journal-title":"Bull World Health Organ."},{"key":"10.1016\/j.inhe.2010.12.001_bib0080","unstructured":"Evaluate vaccination coverage. National Immunization Programme. New Delhi: Government of India, Ministry of Health and Family Welfare;1989."},{"key":"10.1016\/j.inhe.2010.12.001_bib0085","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-3156.2004.01247.x","article-title":"Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa","volume":"9","author":"Babu","year":"2004","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.inhe.2010.12.001_bib0090","first-page":"6","article-title":"Delivery strategy of mass annual single dose DEC administration to eliminate lymphatic filariasis in the urban areas of Pondicherry, South India: 5 years of experience","volume":"24","author":"Nandha","year":"2007","journal-title":"Filaria J"},{"key":"10.1016\/j.inhe.2010.12.001_bib0095","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-3156.2005.01542.x","article-title":"Global elimination of lymphatic filariasis: fact or fantasy?","volume":"11","author":"Gyapong","year":"2006","journal-title":"Trop Med Int Health"},{"issue":"Suppl 2","key":"10.1016\/j.inhe.2010.12.001_bib0100","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1179\/000349802125002419","article-title":"Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities","volume":"96","author":"Burkot","year":"2002","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.inhe.2010.12.001_bib0105","first-page":"4","article-title":"Defining the cost of the Egyptian lymphatic filariasis elimination programme","volume":"2","author":"Ramzy","year":"2005","journal-title":"Filaria J"},{"key":"10.1016\/j.inhe.2010.12.001_bib0110","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4269\/ajtmh.2005.73.753","article-title":"Evaluation of the program to eliminate lymphatic filariasis in Vanuatu following two years of mass drug administration implementation: results and methodologic approach","volume":"73","author":"Fraser","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.inhe.2010.12.001_bib0115","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/j.1365-3156.2006.01626.x","article-title":"Participation in three consecutive mass drug administrations in Leogane Haiti","volume":"11","author":"Mathieu","year":"2006","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.inhe.2010.12.001_bib0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1475-2883-6-11","article-title":"Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka","volume":"6","author":"Weerasooriya","year":"2007","journal-title":"Filaria J"},{"key":"10.1016\/j.inhe.2010.12.001_bib0125","first-page":"51","article-title":"Study on factors affecting the MDA Programme in Kerala state","volume":"39","author":"Showkath","year":"2007","journal-title":"J Commun Dis"},{"key":"10.1016\/j.inhe.2010.12.001_bib0130","first-page":"31","article-title":"Lymphatic filariasis elimination programme in India: an update","volume":"3","author":"Krishnamoorthy","year":"2006","journal-title":"Indian J Lymphol"},{"key":"10.1016\/j.inhe.2010.12.001_bib0135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1475-2883-5-10","article-title":"The argument for integrating vector control with mass drug administration campaigns to ensure elimination of lymphatic filariasis","volume":"5","author":"Burkot","year":"2006","journal-title":"Filaria J."}],"container-title":["International Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/inthealth\/article-pdf\/3\/1\/22\/1923934\/3-1-22.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T02:47:54Z","timestamp":1559962074000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/inthealth\/article-lookup\/doi\/10.1016\/j.inhe.2010.12.001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S1876341310000914"],"URL":"https:\/\/doi.org\/10.1016\/j.inhe.2010.12.001","relation":{},"ISSN":["1876-3413"],"issn-type":[{"value":"1876-3413","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}